Thursday, Jan 23, 2025 · SEC filings

What the smart money revealed on Jan 23

Real insider buys17insiders · $631K
Real insider sales48insiders · $49.9M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

382 insider filings came in. We hid 94 planned (10b5-1) sellers and 201 people whose filings were routine, like grants and tax withholding.

trending_up

Mexico Fund (MXF) President and CEO Alberto Osorio bought $203K

15,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 22
$203K
trending_up

89bio (ETNB) Director Charles McWherter bought $99.8K

15,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 21–22
$99.8K
trending_up

abrdn Global Infrastructure Income Fund (ASGI) Director Thomas Hunersen bought $88.4K

5,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 15
$88.4K
trending_up

Loop Industries (LOOP) Director Laurence Sellyn bought $54.5K

50,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 21–22
$54.5K
trending_down

BlackRock (BLK) Senior Managing Director J. Richard Kushel sold $10.1M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 68,433 shares directly.

Real sale Form 4 Traded Jan 21
$10.1M
trending_down

Delta Air Lines (DAL) CEO Edward Bastian sold $6.41M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 439,819 shares directly.

Real sale Form 4 Traded Jan 22
$6.41M
trending_down

Salesforce (CRM) President and COO Brian Millham sold $235K

Not marked as a planned 10b5-1 sale. Sold 36% of the shares they held directly. Still holds 1,239 shares.

Real sale Form 4 Sold 36% of stake Traded Jan 23
$235K
Show 13 more real buys
Show 45 more real sales
MS Morgan Stanley · Co-President Daniel Simkowitz · Traded Jan 21
$5M
GS Goldman Sachs Group · Chief Legal Officer Kathryn Ruemmler · Traded Jan 21
$4.76M
MS Morgan Stanley · Co-President Andrew Saperstein · Traded Jan 21
$4.2M
MS Morgan Stanley · Head Technology and Operations Michael Pizzi · Traded Jan 21
$2.52M
CAVA Cava Group · CEO and President Brett Schulman · Traded Jan 21
$2.45M
MS Morgan Stanley · Deputy CFO Raja Akram · Traded Jan 21
$2.38M
FHN First Horizon · Chairman D. Bryan Jordan · Traded Jan 22
$2.32M
MS Morgan Stanley · Chief Legal/Admin Officer Eric Grossman · Traded Jan 21
$1.78M
GS Goldman Sachs Group · Chief Accounting Officer Sheara Fredman · Traded Jan 21
$1.28M
MS Morgan Stanley · Chief Client Officer Mandell Crawley · Traded Jan 22
$1.15M
GS Goldman Sachs Group · Global Treasurer Carey Halio · Traded Jan 21
$965K
JBHT J.B. Hunt Transport Services · Director James Thompson · Traded Jan 21
$772K
APLS Apellis Pharmaceuticals · CEO Cedric Francois · Traded Jan 22
$412K
CRM Salesforce · President and CFO Amy Weaver · Traded Jan 23
$298K
CAVA Cava Group · Chief Operations Officer Jennifer Somers · Traded Jan 21
$254K
CAVA Cava Group · CFO Tricia Tolivar · Traded Jan 21
$249K
EXFY Expensify · CEO David Barrett · Traded Jan 21–23
$248K
CRM Salesforce · Co-Founder and CTO Parker Harris · Traded Jan 23
$217K
CRM Salesforce · Pres. and Chief Product Officer R. David Schmaier · Traded Jan 23
$215K
CAVA Cava Group · Chief People Officer Kelly Costanza · Traded Jan 21
$183K
CRM Salesforce · EVP and Chief Accounting Officer Sundeep Reddy · Traded Jan 23
$145K
PHAT Phathom Pharmaceuticals · President and Chief Executive Terrie Curran · Traded Jan 21
$126K
APLS Apellis Pharmaceuticals · Chief Technical Officer Nur Nicholson · Traded Jan 22
$120K
APLS Apellis Pharmaceuticals · Chief Scientific Officer Pascal Deschatelets · Traded Jan 22
$120K
CAVA Cava Group · CLO and Secretary Kenneth Bertram · Traded Jan 21
$114K
CAVA Cava Group · Chief Concept Officer Theodoros Xenohristos · Traded Jan 21
$101K
APLS Apellis Pharmaceuticals · Chief Commercial Officer Adam Townsend · Traded Jan 22
$101K
APLS Apellis Pharmaceuticals · General Counsel David Watson · Traded Jan 22
$101K
APLS Apellis Pharmaceuticals · CFO Timothy Sullivan · Traded Jan 22
$94K
SCS Steelcase · VP Robert Krestakos · Traded Jan 22
$58.7K
ZVIA Zevia PBC · President and CEO Amy Taylor · Traded Jan 21
$54.4K
APLS Apellis Pharmaceuticals · Chief People Officer Karen Lewis · Traded Jan 22
$53.3K
PHAT Phathom Pharmaceuticals · COO Azmi Nabulsi · Traded Jan 21
$52K
ALLO Allogene Therapeutics · EVP of R&D Zachary Roberts · Traded Jan 21
$48.4K
PHAT Phathom Pharmaceuticals · CFO and CBO Molly Henderson · Traded Jan 21
$43.4K
APLS Apellis Pharmaceuticals · Chief Business and Strat Officer Mark DeLong · Traded Jan 22
$42.5K
APLS Apellis Pharmaceuticals · Chief Development Officer Jeffrey Eisele · Traded Jan 22
$39.3K
APLS Apellis Pharmaceuticals · VP/Chief Accounting Officer James Chopas · Traded Jan 22
$33.4K
TVTX Travere Therapeutics · Chief Commercial Officer Peter Heerma · Traded Jan 22
$30K
ZVIA Zevia PBC · SVP Lorna Simms · Traded Jan 21
$18.6K
TVTX Travere Therapeutics · SVP Sandra Calvin · Traded Jan 22
$17.5K
TVTX Travere Therapeutics · CFO Christopher Cline · Traded Jan 22
$16.4K
CORZ Core Scientific · CFO Denise Sterling · Traded Jan 22
$12.5K
CBUS Cibus · Director Gerhard Prante · Traded Jan 21–22
$5.53K
IIIN Insteel Industries · Senior Vice President and COO Richard Wagner · Traded Jan 21
$365

13F season

Holdings as of Dec 31, 2024 are due Feb 14

81 funds have filed so far. 58 filed for the quarter before.

Biggest real insider buys, Jan 17–23

Open-market buys by officers and directors, filed in the 7 days up to Jan 23.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist